• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·BLSM
Share

BlossomHill Therapeutics Stocks

¤ 0Last Updated 07.08.2026

Issuer Rating

Performance

Risk

Recommendation

Sell

¤ 0
Key Takeaways

Risk factor

Profitability factor

Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

07.08.2026 14:59

BlossomHill Therapeutics IPO: Cancer Drug Developer Goes Public

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

07.08.2026 16:09

Iran's chief negotiator accused Trump of "theatrical diplomacy"

07.08.2026 15:30

From Antarctica to the Nasdaq: How Lindblad Expeditions Made a Fortune from a Love of the Wild

07.08.2026 15:14

Morning in New York: Hiring Trends Will Put the Tech Rally to the Test

07.08.2026 15:00

Latigo IPO: A "secret" biotech startup founded by former Amgen employees has gone public

07.08.2026 14:59

BlossomHill Therapeutics IPO: Cancer Drug Developer Goes Public

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026